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Background: Guidance supporting care delivery in the last days of life has been implemented 
across Wales for the past 16 years. Continuous central monitoring and recent developments for 
care of the dying patient in England, provided the impetus to undertake a thorough overhaul of 
the Welsh guidance.
Methods: Recommendations of the National Health Service (NHS) Leadership Alliance for 
Care of Dying People, supported by outcomes of a Welsh electronic survey, resulted in proto-
type guidance being drawn up. The new guidance was tested in a variety of care settings and 
agreement reached it was fit for purpose. 
Outcomes: This paper reports on the progress of reviewing the previous process-led guidance 
to address the current focus on providing individualised care for the patient and those important 
to them at the end-of-life. The new guidance resulting from this process is discussed, quality 
monitoring systems are described and the national progress with implementation across Wales 
reported.
KEY WORDS: Dying patients; Supporting care; Continual quality monitoring; Benchmarking; 
Last days of life.
BACKGROUND
The way we die is important not only for the person dying but more explicitly for those who 
live on. The Economist Intelligence Unit (EIU)1 report ranked end-of-life care in the United 
Kingdom as best in the world, although room for improvement continued to be identified.
 For healthcare professional teams providing care the challenges can be multiple and 
care interventions complex. In 2015, the National Institute for Clinical Excellence (NICE) is-
sued new guidelines to support the delivery of end-of-life care in all care settings.2 In Wales, 
the NHS is devolved to the Welsh Government and managed locally through regional health 
boards. Each health board is responsible for all primary and secondary care provision in its 
area. 
 Based on the National Council for Palliative Care guidelines “Changing Gear”3 the 
‘Welsh Integrated Care Priorities’ (WICP) for the last days of life was developed for use in all 
care settings across Wales.4 The WICP was implemented on an All-Wales basis in 2000 and 
used in all care settings. This work has been reported in full elsewhere.4,5 
 The WICP has been systematically monitored using the variance reporting mechanism 
inherent in the integrated care pathway model.6-8 This national system has informed regular 
feedback to teams across Wales and facilitated benchmarking exercises.9 This level of feedback 
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has been a valued component of the monitoring system.10 In ad-
dition, the WICP has been annually audited against anonymised 
deceased patient’s case-notes since 2006.11 
 Taking account of feedback from healthcare profes-
sionals using the WICP, quality monitoring data from variance 
analysis and annual audit outcomes, the document has been an-
nually reviewed to reflect current changes and recommendations 
in clinical practice. Major review and revision of the documenta-
tion has been undertaken twice over the 15 years of widespread 
use in Wales.
 The recent recommendations of the Neuberger enquiry 
to withdraw the Liverpool Care Pathway,12 and the subsequent 
work of the NHS Leadership Alliance for the Care of Dying Peo-
ple13 provided added impetus to the need for a third major review 
of the WICP. 
 This paper reports on the process of the WICP over-




A multidisciplinary working group was convened with a brief to 
embrace the five priorities of the NHS Leadership Alliance13 and 
produce all-Wales patient-centred guidance to support individu-
alised care in the last days of life, to supersede the WICP.
 Drawing on the strengths of the WICP a prototype doc-
ument was developed by the working group, utilising the much 
valued prompts and ‘triggers’ encapsulated under ‘comfort mea-
sures’ (including communication, environment, symptom con-
trol, mouth care, pressure area care and elimination) and ‘antici-
patory prescribing’.  Although, the patient and those important 
to them are at the centre of discussion and decisions in the last 
days of life, this individualised approach was not always ade-
quately evidenced in the original layout of the WICP. The pro-
totype specifically prompted discussion and decision-making in 
the last days of life, and provided space to document outcomes. 
This evolution of the document has reduced the use of ‘tick-box’ 
or ‘cookbook’ medicine which became a popular criticism of in-
tegrated care pathways.14 
 The first iteration of the document was circulated for 
comments and input within the specialist palliative care com-
munity in Wales, the lead nursing groups and Macmillan GP 
facilitators. Simultaneously, we engaged with patient forums 
to explore their perspectives. They welcomed open discussion 
about care of the dying patient in Wales and offered valuable in-
sights into what was expected of clinicians at this sensitive time, 
contributing to a more refined, second iteration of the prototype. 
 The next step was to canvas the views of healthcare 
professionals (HCP’s) looking after dying patients in other spe-
cialities and settings in Wales. Drawing on material generated by 
consultation with palliative care colleagues and patient groups in 
Wales, an electronic survey (Bristol Online Survey (BOS))15 was 
developed and circulated in both the specialist palliative care 
and generic health-care community. Response was good: 351 
HCPs responded (48.7% nurses, 42.7% doctors) from all care 
settings in Wales. The majority were regularly caring for dying 
patients, and 69.2% were currently utilising the WICP. 
 The free text responses illustrated that formalised feed-
back is required to collect tangible proof of impact and struc-
tured guidance is deemed necessary and highly valued by HCPs.
“Guidance is a good baseline for the NHS and palliative care to 
work from whilst recognising all deaths are individual”
“(It) guides HCPs to ensure reversible causes of deterioration 
have been excluded, to change priority of care and focus on 
comfort and dignity.”
“(It) gives a clear indication of the roles and responsibilities of 
the professionals involved, gives more inexperienced staff confi-
dence and guidance and encourages team working.”
 In light of the survey responses, a third version of the 
prototype guidance was drawn up and circulated for comment, 
agreement and feasibility testing. 
Feasibility Testing
Members of the working group with direct patient contact agreed 
to test 5 uses of the Care Decisions guidance in their workplace, 
resulting in a pragmatic sample of n=40. Positive feedback was 
received from all eight participating sites, and the Care Deci-
sions documentation was considered fit for purpose. Construc-
tive criticism of the exact wording of phrases in the document 
resulted in a fourth iteration of the guidance.
Governance
Each Health Board was expected to approve the Care Decisions 
guidance for use in their areas. This process was led by Betsi 
Cadwaladr University Health Board. The guidance successfully 
underwent equality and diversity assessment and proceeded to 
a quality assurance appraisal which was granted. The Board en-
dorsed a comprehensive programme of education to accompany 
Care Decisions implementation.
OUTCOMES
The suite of documents and education materials can be accessed 
from the ‘Last Days of Life’ section on www.wales.pallcare.info.
Documentation: Care Decisions
The Care Decisions guidance firmly places the patient and those 
important to them at its centre. It is designed to be easily incor-
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porated into the patient’s notes and requires the first two pages 
to be completed and signed by the patient’s GP, Consultant or 
healthcare professional in charge of their care.
 The nursing plan for this episode of care can be out-
lined within the document and recorded fully in the nursing 
notes; existing nursing care plans can run alongside as appro-
priate. Throughout the guidance there are prompts designed to 
promote and document optimum care of the dying patient and 
those important to them. 
 The guidance is accompanied by a case review sheet 
for quality monitoring and is also supported by the provision of 
symptom management guidelines, a symptom assessment sheet, 
syringe driver chart and check list.
Case review sheet: The case review sheet is closely structured 
around the five priorities of care advocated by the NHS Leader-
ship Alliance for the Care of the Dying Person (Table 1).13 Under 
each of the five priorities there are questions with a binary yes/
no reply and a free text box inviting comments. HCPs are en-
couraged to complete a case review sheet for each patient whose 
care was supported by the Care Decisions guidance.
 The anonymised case review sheet is returned to the 
central office via secure fax, e-mail or post for analysis and sub-
sequent feedback.
Symptom management guidelines: In response to a direct re-
quest from HCPs the symptom management guidelines continue 
to be included as a supporting resource. Although, the informa-
tion contained within this document is accessible in the British 
National Formulary17 and the Welsh guidelines,18 its usefulness 
in one document directly associated with the guidelines drew 
universal agreement amongst colleagues. Each area has the op-
tion to include contact details for obtaining specialist palliative 
care advice (Table 2).
Symptom assessment sheet: Used in a similar manner to a rou-
tine observation chart, the symptom assessment sheet provides 
an ‘at a glance’ summary of symptoms over time including pain, 
agitation, nausea/vomiting and excess respiratory secretions or 
rattle that may require clinical review and subsequent input.
 The chart does not carry any prescriptive directions for 
specific observation times thus allowing for its application in a 
Table 1: Five Priorities of Care Advocated by the NHS Leadership Alliance for Care of Dying People
1
The possibility that the person may die within the coming days and hours is recognised and communicated 
clearly, decisions about care are made in accordance with the person’s needs and wishes and these are 
reviewed and revised regularly.
2 Sensitive communication takes place between staff, the person who is dying and those important to them.
3 The dying person and those important to them are involved in discussions about treatment and care.
4 The people important to the dying person are listened to and their needs are respected.
5 Care is tailored to the individual and delivered with compassion-with an individual care plan in place
Leadership Alliance for the Care of Dying People. One chance to get it right.13
Table 2: Commonly used PRN Medicines and Doses for End-of-Life Care.
Indication Drug Dose Frequency Route
Pain Morphine * 2-4 hrly SC
Nausea/Vomiting Cyclizine 50 mg 4 hrly  (max 150 mg/24 hr ) SC
Haloperidol 1.25-1.5 mg 4 hrly SC
Levomepromazine 6.25 mg 4 hrly SC
Anxiety/Distress Midazolam 2.5 or 5 mg 2 hrly SC
Respiratory Secretions Hyoscine hydrobromide 400 micrograms 4 hrly (max 2.4 mg / 24 hr) SC
Glycopyrronium 200 micrograms 4 hrly  (max 1.2 mg / 24 hr) SC
*Opioid prescriptions should be tailored according to the patient’s circumstances:
For a patient on regular opioid analgesics: calculate one sixth of the 24-hour dose for PRN use. Some patients will be able to continue 
with oral morphine liquid. 
All Wales Guidance to Support Care in the Last Days of Life: Symptom Control Guidance
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Syringe driver prescription chart: Some patients in the last days 
of life will require the use of regular medication via continuous 
subcutaneous infusion (CSCI) (usually delivered via a syringe 
driver or pump). The recent development and publication of an 
All-Wales Continuous Subcutaneous Infusion Medication Ad-
ministration Record (hence referred to as ‘syringe driver pre-
scription chart’) coincided with the implementation of the Care 
Decisions guidance.19 
 This development introduced consistency to CSCI pre-
scriptions. In addition to the syringe driver prescription chart, the 
use of a local syringe driver check chart or check list is strongly 
advocated for safety monitoring. 
Medication prescription in the community setting: There is 
currently no standardised All-Wales prescription chart for use 
in the community setting and documentation varies between 
geographical areas. A combined medication prescription and 
administration record chart on which as-needed and other regu-
lar medication could be prescribed was therefore included. This 
contains prompts for prescribers to include medication for com-
mon symptoms of pain, nausea/vomiting, agitation and excess 
respiratory secretions.
Monitoring & Evaluation
There is a current expectation of clinical teams to demonstrate 
a consistently high standard of quality care and evidence a con-
tinual drive to improve care at the end-of-life.20
 The Care Decisions project retains the established cen-
tralised system of monitoring and evaluation. This permits a 
continuation of quality monitoring and also offers an estimate of 
how often the Care Decisions guidance was used. The annual au-
dit of the Care Decisions guidance against anonymised deceased 
patient’s case-notes will continue. 
 The case review sheets are being returned from several 
areas across Wales and indicate that Priority 1 was met in 66% 
of cases, Priority 2 in 75%, Priority 3 in 87% and Priority 4 and 
5, 93% and 86% respectively. However, this is a small sample 
(n=240) and outcomes at this stage should be viewed with cau-
tion.
Implementation & Education
Building on previous success implementing the WICP a “top-
down, bottom-up” model was retained with a strong emphasis 
on local ownership and firm engagement with Health Boards. 
From the ‘top-down’ the Care Decisions guidance has endorse-
ment from the Welsh Government. Progress with the change-
over is centrally monitored by the Project Manager.
Education: A multidisciplinary group collaborated on the devel-
opment of an education package to support the implementation 
of the Care Decisions guidance. Two versions were developed 
– a short (20-30 minute) and a long (45 minute) version. Slides, 
notes and teaching support tips are incorporated as well as a 3 
minute case scenario video to help focus learners on the session. 
 An e-learning version is also in development. Anecdot-
al feedback on the education resource is positive, highlighting 
the value of a consistent approach across Wales.
DISCUSSION
 
This paper details the evolution of guidance to support care in 
the last days of life in Wales, incorporating strengths of previous 
work and utilising the impetus provided by the national debate 
on end-of-life care. It explains the function of a centralised data 
collection, analysis and feedback system, outlines the current 
implementation and future evaluation and sustainability. Su-
perseding existing end-of-life care systems with new guidance 
has implications for practice and policy: A centralised quality 
monitoring system supports effective changeover from existing 
system to new guidance. 
 Through the process of continual quality monitoring, 
annual audit and review, the guidance can be kept dynamic and 
flexible to meet the needs of the individual patient, those impor-
tant to them and the HCPs delivering care. Structured documen-
tation provides a tangible way of evidencing the implementa-
tion of national guidance to support care in the last days of life. 
It enables clinical teams to demonstrate working to guidance 
grounded in evidence where available and best accepted care.
 The Care Decisions guidance is comprised of four sides 
of A4 print, the Case Review Sheet and additional resources as 
described above. In total, this results in seven documents includ-
ing the ‘as needed’ medication prescription sheet, continuous 
subcutaneous infusion medication administration record and 
check chart.
 Each document is a stand-alone document however 
they all complement each other as a care delivery pack. There 
is a question about whether the documents would be best suited 
as a ‘one-click delivers all’ particularly in a busy care setting 
whereby the additional supporting documents may be over-
looked. 
 The counter argument is that a ‘pick and mix’ format 
allows documents to be accessed to suit individual patient needs. 
To resolve the question of one document or several, we will seek 
a consensus view from HCPs.
 The changeover from Care Priorities to Care Decisions 
is on-going and expected to be complete by April 2017. 
 The identification of barriers and enablers to the 
changeover will be an important future piece of work, as will 
further electronic surveys of healthcare professionals to detail 
their satisfaction with the new guidance, supporting documents 
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and teaching package. The collection and analysis of more Case 
Review sheets is expected to lead to a better understanding of 
care delivery in different care settings, inform feedback for 
teams across the country and facilitate teaching and education. 
Further work is needed to develop robust systems for evaluation 
of care in the last days of life, drive up standards and provide 
the very best to support each individual, their families and their 
health carers.
CONCLUSION
Developing a tool that advocates standardised care in the last 
days of life is not feasible – care at this stage needs to be in-
dividual and patient centred rather than documentation driven. 
However, for some healthcare professionals who lack confi-
dence in care of the dying, prompts and clinical guidance can be 
invaluable to help the delivery of consistently high quality care. 
One of the challenges highlighted by the electronic survey was 
to provide a document that prompts rather than hinders thought, 
promotes care rather than curtails it.
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